Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,873,048
  • Shares Outstanding, K 104,169
  • Annual Sales, $ 4,676 M
  • Annual Income, $ 131,260 K
  • 60-Month Beta 1.84
  • Price/Sales 1.25
  • Price/Cash Flow 10.81
  • Price/Book 1.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.36
  • Number of Estimates 5
  • High Estimate 0.41
  • Low Estimate 0.21
  • Prior Year 0.61
  • Growth Rate Est. (year over year) -40.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.33 +12.02%
on 06/15/20
59.11 -4.62%
on 07/06/20
-0.63 (-1.11%)
since 06/10/20
3-Month
46.27 +21.85%
on 04/15/20
64.29 -12.30%
on 06/03/20
+6.77 (+13.65%)
since 04/09/20
52-Week
30.02 +87.81%
on 03/18/20
74.25 -24.07%
on 03/04/20
+7.38 (+15.06%)
since 07/10/19

Most Recent Stories

More News
Syneos Health Bolsters Communications Leadership Team

Tim Pantello Appointed to Lead One of the World's Largest Healthcare-Only Agency Portfolios

SYNH : 56.38 (+0.25%)
Syneos Health Schedules Second Quarter 2020 Earnings Call for Thursday, August 6, 2020

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2020 financial results on Thursday, August 6, 2020, prior to its earnings...

SYNH : 56.38 (+0.25%)
Senseonics Holdings (SENS) Catches Eye: Stock Jumps 5.7%

Senseonics Holdings (SENS) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

SENS : 0.4194 (+0.87%)
SYNH : 56.38 (+0.25%)
Allscripts (MDRX) Looks Good: Stock Adds 9.1% in Session

Allscripts (MDRX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

MDRX : 6.60 (+2.64%)
SYNH : 56.38 (+0.25%)
10x Genomics (TXG) Looks Good: Stock Adds 6.2% in Session

10x Genomics (TXG) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

SYNH : 56.38 (+0.25%)
TXG : 91.06 (-1.33%)
Syneos Health (SYNH) Up 9.3% Since Last Earnings Report: Can It Continue?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SYNH : 56.38 (+0.25%)
Daiichi Sankyo and Syneos Health(R) Form Strategic Coalition for Development of Daiichi Sankyo's ADC Oncology Pipeline

Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) announced that it has entered into a strategic agreement with Syneos Health(R) (Nasdaq:SYNH). The companies are coming together to form a coalition to accomplish...

SYNH : 56.38 (+0.25%)
Syneos Health to Present at Upcoming Investor Conferences

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 56.38 (+0.25%)
Syneos Health to Present at the UBS Virtual Global Healthcare Conference

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 56.38 (+0.25%)
Syneos Health (SYNH) Tops Q1 Earnings Estimates, Margins Down

The coronavirus impact results in inaccessibility of several of Syneos Health's (SYNH) clinical trial sites.

BIIB : 278.88 (+0.06%)
LLY : 163.36 (-1.86%)
SYNH : 56.38 (+0.25%)
APHA : 4.30 (+2.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade SYNH with:

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

2nd Resistance Point 57.52
1st Resistance Point 56.95
Last Price 56.38
1st Support Level 55.75
2nd Support Level 55.11

See More

52-Week High 74.25
Fibonacci 61.8% 57.35
Last Price 56.38
Fibonacci 50% 52.14
Fibonacci 38.2% 46.92
52-Week Low 30.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar